Meta Iodobenzylguanidine Therapy
Fig. 1 Discordant mIBG/FDG PET imaging. Patient with metastatic phaeochromocytoma, referred for mIBG therapy. a 131I mIBG anterior whole body imaging shows focal abnormal uptake in the superior thoracic spine and…
Fig. 1 Discordant mIBG/FDG PET imaging. Patient with metastatic phaeochromocytoma, referred for mIBG therapy. a 131I mIBG anterior whole body imaging shows focal abnormal uptake in the superior thoracic spine and…
Fig. 1 Images of a patient with a follicular lymphoma relapse. a FDG-PET recorded before RIT showed an abnormal focus in the mediastinum. b FDG-PET demonstrated a metabolic complete response as…
Generic name Trade name Agent/Target Cancer indication Approval Unconjugated Rituximab Rituxan Chimeric anti-CD20 IgG1 B cell lymphoma 1997 Trastuzumab Herceptin Humanized anti-HER2 IgG1 Breast 1998 Alemtuzumab Campath-1H Humanized anti-CD52 CLL…
Aggressive histologic types Diffuse large B cell lymphoma Mantle cell lymphoma Lymphoblastic lymphoma CNS lymphoma Immunoblastic lymphoma AIDS-related lymphoma Indolent histologic subtypes Follicular lymphomas Diffuse small lymphocytic lymphomas/CLL Lymphoplasmacytic lymphomas…
Age/gender Histology/location Treatment before/after targeted RT* Total activity (MBq)/radionuclide Barthel index before/at the end of targeted RT Survival after initiation of targeted RT Overall sur-vivala Glioblastomas 37/F G/fL S-R-C 375/213Bi…
Fig. 1 Immunoscintigraphy (anterior and posterior views) performed in a MTC patient. The images show good tumor targeting in liver and brain metastases Fig. 2 Post-RIT biological response. The figure shows stabilization,…
© Springer-Verlag Berlin Heidelberg 2012Richard P. Baum (ed.)Therapeutic Nuclear MedicineMedical Radiology10.1007/174_2012_734 Treatment of Lymphoma with 131I-Chimeric Monoclonal Antibodies J. Harvey Turner1 (1) School of Medicine and Pharmacology, Department of Nuclear Medicine, The University of…
Fig. 1 a + b: Re-188 HEDP uptake in a patient with prostate cancer disease with osseous metastases. a Whole-body scan after first Re-188 HEDP treatment, b whole-body scan after second Re-188 HEDP…
© Springer-Verlag Berlin Heidelberg 2012Richard P. Baum (ed.)Therapeutic Nuclear MedicineMedical Radiology10.1007/174_2012_727 Radioembolization (Yttrium-90 Microspheres) for Metastatic Hepatic Malignancies Andrew S. Kennedy1, 2 (1) FACRO Co-Medical Director, Wake Radiology Oncology, 300 Ashville Ave Suite 110, Cary,…
© Springer-Verlag Berlin Heidelberg 2012Richard P. Baum (ed.)Therapeutic Nuclear MedicineMedical Radiology10.1007/174_2012_733 Radioembolization: Clinical Results Hepatocellular Carcinoma Ahsun Riaz1, Laura M. Kulik2 and Riad Salem3 (1) Division of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, IL, USA…